Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04877730 · ClinicalTrials.gov registry record · NA

Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation

A NA study of Type 1 Diabetes, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04877730 is a NA study of Type 1 Diabetes that has completed, run by University of Virginia. The registered enrollment target is 50 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04877730, a NA study of Type 1 Diabetes, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the meal anticipation module on a closed loop algorithm, assessing efficacy and safety.

Conditions Studied

Interventions

  • DEVICE Fully Closed Loop (FCL)
  • DEVICE Fully Closed Loop with meal anticipation module (FCL+)
  • DEVICE Hybrid Closed Loop (HCL)

Study Locations (1)

Virginia

  • University of Virginia Center for Diabetes Technology - Charlottesville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-05-21
Est. Completion 2022-03-06
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT04877730

The ClinicalTrials.gov registry entry for NCT04877730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (94% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Fully Closed Loop (FCL) is the first listed.

NCT04877730 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04877730 about?

NCT04877730 is a clinical study titled "Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation". The purpose of this study is to test the meal anticipation module on a closed loop algorithm, assessing efficacy and safety.

What is the current status of trial NCT04877730?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-05-21. Estimated completion is 2022-03-06.

What conditions does trial NCT04877730 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT04877730?

The interventions under investigation include: Fully Closed Loop (FCL) (DEVICE), Fully Closed Loop with meal anticipation module (FCL+) (DEVICE), Hybrid Closed Loop (HCL) (DEVICE).

Who is sponsoring clinical trial NCT04877730?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04877730 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.